Quetiapine: novel uses in the treatment of depressive and anxiety disorders

Author： Ravindran Arun V Al-Subaie Abdullah Abraham Gebrehiwot

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.10, 2010-10, pp. : 1187-1204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel uses for risperidone: focus on depressive, anxiety and behavioral disorders

By Ravindran Arun V Bradbury Cheryl McKay Martha da Silva Tricia L

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1693-1710

Informa Healthcare

Access to resources Recommend Favorite

Aripiprazole in the Treatment of Depressive and Anxiety Disorders: A Review of Current Evidence

By Pae Chi-Un Serretti Alessandro

CNS Drugs, Vol. 22, Iss. 5, 2008-01 ,pp. : 367-388

Adis International

Access to resources Recommend Favorite

Managing depressive and anxiety disorders with escitalopram

By Thase Michael E

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 4, 2006-03 ,pp. : 429-440

Informa Healthcare

Access to resources Recommend Favorite

Editorial: Are We in Need for Novel Therapeutics in Anxiety Disorders? (Thematic Issue: Non-Antidepressant Long Term Treatment of Anxiety Disorders)

Current Clinical Pharmacology, Vol. 10, Iss. 2, 2015-01 ,pp. : 84-85

Bentham Science Publishers

Access to resources Recommend Favorite

Assessment of the evolution of anxiety during a treatment of major depressive disorders in ambulatory patients in general practice with fluoxetine (Prozac) 20 mg

By Mesters P. Martens S. Taymans J.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 290-291

Elsevier

Access to resources Recommend Favorite